MICROBOT MEDICAL INC. Proceeds from Debt, Net of Issuance Costs
MICROBOT MEDICAL INC. (MBOT) reported Proceeds from Debt, Net of Issuance Costs of $4.30 million for the 1-month period ending 2022-10-31, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2022-11-14
- 2022-10-31: Proceeds from Debt, Net of Issuance Costs 1 month $4.30M.
| Period end | Proceeds from Debt, Net of Issuance Costs 1 month |
|---|---|
| 2022-10-31 | $4.30M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |